That is the net model of our BIO 2025 publication. Get extra BIO updates on to your inbox by signing up right here, and join our morning biotech information roundup publication right here.
Whats up all,
I’ve a contemporary double shot of espresso in hand, which I’m certain would please my colleague Ed Silverman, aka Pharmalot. BIO has been busy this yr. From what I’m listening to on the bottom, attendance is sort of good, with executives and business reps flocking to the convention for steering on federal coverage, AI, and world competitors.
